What is Sabina Omerhodzic's specialty?

Sabina Omerhodzic (NPI 1437359569) is a Medicare-billing provider whose primary specialty is Otolaryngology in Bronx, NY.

Where does Sabina Omerhodzic practice?

Sabina Omerhodzic practices in Bronx, NY, based on the location reported in the CMS Medicare provider datasets for NPI 1437359569.

How much does Medicare pay Sabina Omerhodzic?

Medicare Part B utilization, prescribing (Part D), MIPS quality scores, and industry payments for Sabina Omerhodzic (NPI 1437359569) are detailed on this CareTrace profile.

PROVIDER PROFILE · NPI 1437359569

Sabina Omerhodzic

PRACTICESSY ACUPUNCTURE PLLCSee all providers at this practice →

OtolaryngologyBronx, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

No data available for this provider in 2024.

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$51

Payment records

By payment type

Food and Beverage$51

Top paying entities

Food and Beverage$51

REFERRAL NETWORK

Where Sabina Omerhodzic's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION	37	169
Alexandera Clarke Physician Assistant · Elmer, NJ	14	22

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION	19	75

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history